Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    July 2019
  1. LIAO KF, Lai SW
    Association Between Inflammatory Bowel Disease and Hip Fracture.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000344.
    PubMed     Text format    


    June 2019
  2. KNOX NC, Forbes JD, Peterson CL, Van Domselaar G, et al
    The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Am J Gastroenterol. 2019 Jun 20. doi: 10.14309/ajg.0000000000000305.
    PubMed     Text format     Abstract available


  3. PITTET LF, Verolet CM, Michetti P, Girardin M, et al
    High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jun 13. doi: 10.14309/ajg.0000000000000289.
    PubMed     Text format     Abstract available


    May 2019
  4. MANOSA M, Chaparro M, Juan A, Arajol C, et al
    Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.
    Am J Gastroenterol. 2019;114:771-776.
    PubMed     Text format     Abstract available


    April 2019
  5. SINGH S, Proudfoot J, Dulai PS, Jairath V, et al
    Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2019 Apr 29. doi: 10.14309/ajg.0000000000000254.
    PubMed     Text format    


  6. LONG MD, Rubin DT
    Histologic Remission in Ulcerative Colitis: Are We There Yet?
    Am J Gastroenterol. 2019 Apr 22. doi: 10.14309/ajg.0000000000000235.
    PubMed     Text format     Abstract available


  7. MENON T, Afzali A
    Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care.
    Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000222.
    PubMed     Text format     Abstract available


    March 2019
  8. UNGARO R, Colombel JF, Lissoos T, Peyrin-Biroulet L, et al
    A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review.
    Am J Gastroenterol. 2019 Mar 22. doi: 10.14309/ajg.0000000000000183.
    PubMed     Text format     Abstract available


  9. BARNES EL, Kappelman MD, Long MD, Evon DM, et al
    A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Mar 1. doi: 10.14309/ajg.0000000000000177.
    PubMed     Text format     Abstract available


  10. RUBIN DT, Ananthakrishnan AN, Siegel CA, Sauer BG, et al
    ACG Clinical Guideline: Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2019;114:384-413.
    PubMed     Text format     Abstract available


    February 2019
  11. HATA K, Anzai H, Ikeuchi H, Futami K, et al
    Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
    Am J Gastroenterol. 2019 Feb 8. doi: 10.14309/ajg.0000000000000117.
    PubMed     Text format     Abstract available


  12. LUDVIGSSON JF, Mahl M, Sachs MC, Bjork J, et al
    Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.
    Am J Gastroenterol. 2019;114:291-304.
    PubMed     Text format     Abstract available


    January 2019
  13. SIEGEL CA
    Placing Value on Telemedicine for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jan 30. doi: 10.14309/ajg.0000000000000151.
    PubMed     Text format     Abstract available


  14. BATTAT R, Duijvestein M, Guizzetti L, Choudhary D, et al
    Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2019 Jan 25. doi: 10.14309/ajg.0000000000000111.
    PubMed     Text format     Abstract available


  15. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us?
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000070.
    PubMed     Text format    


    November 2018
  16. SHEN B, Kochhar G, Hull TL
    Bridging Medical and Surgical Treatment of Inflammatory Bowel Disease: The Role of Interventional IBD.
    Am J Gastroenterol. 2018 Nov 21. pii: 10.1038/s41395-018-0416.
    PubMed     Text format    


  17. VERNERO M, Astegiano M, Ribaldone DG
    New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0422.
    PubMed     Text format    


  18. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Shen N, et al
    Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes.
    Am J Gastroenterol. 2018 Nov 12. pii: 10.1038/s41395-018-0417.
    PubMed     Text format     Abstract available


  19. CROSS RK, Langenberg P, Regueiro M, Schwartz DA, et al
    A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0272.
    PubMed     Text format     Abstract available


  20. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Nov 2. pii: 10.1038/s41395-018-0401.
    PubMed     Text format     Abstract available


    October 2018

  21. Inflammatory Bowel Disease (Abstracts 568-744).
    Am J Gastroenterol. 2018 Oct 25. pii: 10.1038/s41395-018-0296.
    PubMed     Text format    


  22. CHAPARRO M, Gisbert JP
    Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.
    Am J Gastroenterol. 2018 Oct 24. pii: 10.1038/s41395-018-0379.
    PubMed     Text format    


  23. BYE WA, Ma C, Nguyen TM, Parker CE, et al
    Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0354.
    PubMed     Text format     Abstract available


  24. MA D, Wong W, Aviado J, Rodriguez C, et al
    Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0368.
    PubMed     Text format     Abstract available


  25. SCHARL S, Barthel C, Rossel JB, Biedermann L, et al
    Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0360.
    PubMed     Text format     Abstract available



  26. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0312.
    PubMed     Text format    



  27. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0342.
    PubMed     Text format    



  28. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0327.
    PubMed     Text format    


    September 2018
  29. ALMARIO CV, Chen MS, Spiegel BMR
    Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0279.
    PubMed     Text format    


  30. NG SC, Kaplan GG, Tang W, Banerjee R, et al
    Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0233.
    PubMed     Text format     Abstract available


    August 2018
  31. JAIRATH V
    Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Am J Gastroenterol. 2018 Aug 29. pii: 10.1038/s41395-018-0224.
    PubMed     Text format     Abstract available


  32. AXELRAD JE, Joelson A, Green PHR, Lawlor G, et al
    Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Aug 3. pii: 10.1038/s41395-018-0211.
    PubMed     Text format     Abstract available


    July 2018
  33. FELD LD, Rubin DT, Feld AD
    Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
    Am J Gastroenterol. 2018 Jul 16. pii: 10.1038/s41395-018-0204.
    PubMed     Text format    


  34. FRIEDMAN S, Magnussen B, O'Toole A, Fedder J, et al
    Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Am J Gastroenterol. 2018 Jul 10. pii: 10.1038/s41395-018-0177.
    PubMed     Text format     Abstract available


  35. JOHNSON FR, Reed S, Gonzalez JM
    Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Jul 3. pii: 10.1038/s41395-018-0186.
    PubMed     Text format    


    June 2018
  36. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0162.
    PubMed     Text format     Abstract available


  37. SINGH S, Proudfoot JA, Dulai PS, Jairath V, et al
    No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0144.
    PubMed     Text format     Abstract available


  38. NHU QM, Chiao H, Moawad FJ, Bao F, et al
    The Anti-alpha4beta7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0145.
    PubMed     Text format    


  39. LEVENSTEIN S, Prantera C
    Depression and Disease Course in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0111.
    PubMed     Text format    


  40. MAO R, Chen MH
    Networked Clinical Study Collaboration on Inflammatory Bowel Disease in China.
    Am J Gastroenterol. 2018 Jun 7. pii: 10.1038/s41395-018-0148.
    PubMed     Text format    


  41. MOHAPATRA S, Singh DP, Alcid D, Pitchumoni CS, et al
    Beyond O&P Times Three.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0083.
    PubMed     Text format     Abstract available


    May 2018
  42. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Text format     Abstract available


  43. SCHILLER LR
    Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0032.
    PubMed     Text format     Abstract available


    April 2018
  44. MATSUSHITA M, Fukata N, Omiya M, Nishio A, et al
    Pathophysiology of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:622.
    PubMed     Text format    


    March 2018
  45. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Text format     Abstract available


  46. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Text format     Abstract available


  47. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed     Text format    


    February 2018
  48. DAI C, Jiang M, Cao Q
    Association between Depression and More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0016.
    PubMed     Text format    


  49. CHAPARRO M, Verreth A, Lobaton T, Gravito-Soares E, et al
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg2017501. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  50. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Text format     Abstract available


  51. DULAI PS, Buckey JC Jr., Raffals LE, Swoger JM, et al
    Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0005.
    PubMed     Text format     Abstract available


  52. BARNES EL, Kappelman MD
    Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.
    Am J Gastroenterol. 2018;113:273-275.
    PubMed     Text format     Abstract available


  53. TOMINAGA K, Tsuchiya A, Honda Y, Abe T, et al
    A Case of Panenteritis With Massive IgG4-Positive Plasma Cell Infiltration Developed 26 Years After Total Proctocolectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:173.
    PubMed     Text format    


    January 2018
  54. LEWIS JD, Scott FI, Brensinger CM, Roy JA, et al
    Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jan 16. pii: ajg2017479. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  55. JEURING SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, et al
    Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2018 Jan 9. pii: ajg2017482. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    December 2017
  56. TAKENAKA K, Ohtsuka K, Kitazume Y, Matsuoka K, et al
    Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017464. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  57. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  58. MA C, Moran GW, Benchimol EI, Targownik LE, et al
    Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.
    Am J Gastroenterol. 2017;112:1840-1848.
    PubMed     Text format     Abstract available


    November 2017
  59. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  60. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  61. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Text format     Abstract available


  62. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed     Text format    


    October 2017
  63. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available



  64. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  65. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  66. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  67. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    


  68. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed     Text format    


  69. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


  70. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Text format     Abstract available


  71. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Text format     Abstract available


    September 2017
  72. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed     Text format    


  73. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Text format     Abstract available


    August 2017
  74. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    July 2017
  75. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  76. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  77. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  78. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed     Text format    


  79. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed     Text format    


    June 2017
  80. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  81. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  82. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed     Text format    


    May 2017
  83. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  84. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    April 2017
  85. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    March 2017
  86. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed     Text format    


  87. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Text format     Abstract available


    February 2017
  88. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Text format     Abstract available


  89. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Text format     Abstract available


    January 2017
  90. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  91. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format    


  92. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  93. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed     Text format    


  94. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed     Text format    


  95. CUI DJ, Zhao X, Hu M
    Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2017;112:185.
    PubMed     Text format    


    December 2016
  96. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  97. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed     Text format    


    November 2016
  98. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed     Text format    


    October 2016
  99. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  100. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available



  101. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  102. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  103. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  104. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    


  105. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed     Text format    


  106. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Text format     Abstract available


    June 2016
  107. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed     Text format    


    May 2016
  108. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: